Bdparp 150 Tablet Substitute
Composition:
OLAPARIB-150MG
Uses:
Cancer (Ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer)
Medicinal Benefits:
Bdparp 150 Tablet contains Olaparib, a targeted drug called a
Bdparp 150 Tablet contains Olaparib, a targeted drug called a PARP inhibitor. PARP is a protein that helps damaged cells to repair themselves. Olaparib stops PARP working. Some cancer cells rely on PARP to keep their DNA healthy. So, the cancer cells die when Olaparib stops PARP from repairing DNA damage.
If you are allergic to Olaparib or any other ingredients in this medication, are breastfeeding, or have too low blood cell counts, you should not use Bdparp 150 Tablet .
Yes, Bdparp 150 Tablet can cause low neutrophils levels, a type of white blood cells that help fight infections. If your white blood cells become low, you can be at higher risk for infections. Tell your doctor if you develop a fever or have an infection.
Do not have immunizations/vaccinations without talking to your doctor first. Also, avoid contact with people who recently had immunizations /vaccinations.
Yes, Olaparib was generally a well-tolerated medication. Take Bdparp 150 Tablet pills exactly as directed by your healthcare provider. Do not change your dose or stop taking Bdparp 150 Tablet unless your healthcare physician instructs you. If you encounter side symptoms, your healthcare provider may temporarily discontinue your Bdparp 150 Tablet therapy or adjust your Bdparp 150 Tablet dose.